Takeda Ventures, Inc.

Takeda Ventures, Inc. is the corporate venture capital arm of Takeda Pharmaceutical Company Limited, established in 2001 to generate disruptive technologies and therapeutic solutions for patients through venture-based investments. The firm focuses on high-caliber, therapeutic, platform-based companies worldwide, specifically investing in early-stage, preclinical opportunities that complement Takeda’s pipeline. Its mission is to create strategic growth opportunities for Takeda by building, managing, and investing in innovative companies. The investment strategy of Takeda Ventures centers on areas aligned with Takeda’s R&D pillars, including Oncology, Rare Genetics & Hematology, Neuroscience, and Gastrointestinal and Inflammation. By partnering with academic innovators, entrepreneurs, and venture investors, Takeda Ventures aims to support therapeutic innovation by providing access to the resources of a multinational pharmaceutical company. This approach fosters the development of novel treatments and accelerates the advancement of promising therapies. With a global presence, Takeda Ventures operates alongside Takeda’s R&D sites in Cambridge, Massachusetts, and San Diego, California. The firm emphasizes collaborative interactions that result in synergies with Takeda's considerable R&D resources, striving to build a portfolio of strategic investments that drive innovation and address unmet medical needs across various therapeutic areas.

Innovative biotechnology and pharmaceutical companies, Early-stage, preclinical opportunities, Alignment with Takeda’s R&D pillars: Oncology, Rare Genetics & Hematology, Neuroscience, Gastrointestinal and Inflammation